APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neurokinin Receptor Antagonists API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neurokinin Receptor Antagonists API Market Analysis and Forecast 2026-2032

Report ID 174016530229 December 2025219 pages

Choose your research edition.

Industry ResearchNeurokinin Receptor Antagonists API Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurokinin Receptor Antagonists API Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Neurokinin Receptor Antagonists API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurokinin Receptor Antagonists API Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurokinin Receptor Antagonists API Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Neurokinin Receptor Antagonists API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neurokinin Receptor Antagonists API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neurokinin Receptor Antagonists API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neurokinin Receptor Antagonists API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neurokinin Receptor Antagonists API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Neurokinin Receptor Antagonists API include Zhejiang Tiantai Pharmaceutical, Humanwell Pharmaceutical, Viwit, Sichuan Qingmu Pharmaceutical, Kelun Pharmaceutical, Shandong New Time Pharmaceutical, Shandong Anxin Pharmaceutical, Qilu Pharmaceutical and Luoxin Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neurokinin Receptor Antagonists API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neurokinin Receptor Antagonists API, also provides the sales of main regions and countries. Of the upcoming market potential for Neurokinin Receptor Antagonists API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurokinin Receptor Antagonists API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurokinin Receptor Antagonists API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neurokinin Receptor Antagonists API sales, projected growth trends, production technology, application and end-user industry.

Neurokinin Receptor Antagonists API Segment by Company

Zhejiang Tiantai Pharmaceutical

Humanwell Pharmaceutical

Viwit

Sichuan Qingmu Pharmaceutical

Kelun Pharmaceutical

Shandong New Time Pharmaceutical

Shandong Anxin Pharmaceutical

Qilu Pharmaceutical

Luoxin Pharmaceuticals

Lianyungang Runzhong Pharmaceutical

Wisdom Pharmaceutical

Hansoh Pharma

United Pharma

Hangzhou Jiuyuan Gene Engineering

Beijing Sjar Technology Development

Zydus Animal Health And Investments

Taizhou Crene Biotechnology

Solara Active Pharma Sciences

Procos

Piramal Pharma

Optimus Pharma

Murli Krishna Pharma

MSN Laboratories

Jubilant Pharmova

Helsinn Advanced Synthesis

Glenmark Life Sciences

Dr. Reddy's Laboratories

Clearsynth Labs

Camus Pharma

Andenex

Neurokinin Receptor Antagonists API Segment by Type

Aprepitant

Fezolinetant

Fosaprepitant

Rolapitant

Maropitant

Netupitant

Neurokinin Receptor Antagonists API Segment by Application

Injections

Tablets

Oral Suspension

Capsules

Other

Neurokinin Receptor Antagonists API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurokinin Receptor Antagonists API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurokinin Receptor Antagonists API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurokinin Receptor Antagonists API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neurokinin Receptor Antagonists API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neurokinin Receptor Antagonists API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurokinin Receptor Antagonists API sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neurokinin Receptor Antagonists API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Aprepitant Major Manufacturers Table 3. Fezolinetant Major Manufacturers Table 4. Fosaprepitant Major Manufacturers Table 5. Rolapitant Major Manufacturers Table 6. Maropitant Major Manufacturers Table 7. Netupitant Major Manufacturers Table 8. Global Neurokinin Receptor Antagonists API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Injections Major Manufacturers Table 10. Tablets Major Manufacturers Table 11. Oral Suspension Major Manufacturers Table 12. Capsules Major Manufacturers Table 13. Other Major Manufacturers Table 14. Neurokinin Receptor Antagonists API Industry Trends Table 15. Neurokinin Receptor Antagonists API Industry Drivers Table 16. Neurokinin Receptor Antagonists API Industry Opportunities and Challenges Table 17. Neurokinin Receptor Antagonists API Industry Restraints Table 18. Global Neurokinin Receptor Antagonists API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Neurokinin Receptor Antagonists API Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Neurokinin Receptor Antagonists API Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Neurokinin Receptor Antagonists API Revenue Market Share by Region (2021-2026) Table 22. Global Neurokinin Receptor Antagonists API Revenue Market Share by Region (2027-2032) Table 23. Global Neurokinin Receptor Antagonists API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 24. Global Neurokinin Receptor Antagonists API Sales by Region (2021-2026) & (Tons) Table 25. Global Neurokinin Receptor Antagonists API Sales by Region (2027-2032) & (Tons) Table 26. Global Neurokinin Receptor Antagonists API Sales Market Share by Region (2021-2026) Table 27. Global Neurokinin Receptor Antagonists API Sales Market Share by Region (2027-2032) Table 28. Global Neurokinin Receptor Antagonists API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Neurokinin Receptor Antagonists API Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Neurokinin Receptor Antagonists API Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Neurokinin Receptor Antagonists API Sales Market Share by Manufacturers (2021-2026) Table 32. Global Neurokinin Receptor Antagonists API Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 33. Global Neurokinin Receptor Antagonists API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Neurokinin Receptor Antagonists API Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Neurokinin Receptor Antagonists API Manufacturers, Product Type & Application Table 36. Global Neurokinin Receptor Antagonists API Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Neurokinin Receptor Antagonists API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Neurokinin Receptor Antagonists API Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Neurokinin Receptor Antagonists API Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Neurokinin Receptor Antagonists API Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2021-2026) Table 43. Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2027-2032) Table 44. Global Neurokinin Receptor Antagonists API Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 45. Global Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 46. Global Neurokinin Receptor Antagonists API Sales by Type (2027-2032) & (Tons) Table 47. Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2026) Table 48. Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2027-2032) Table 49. Global Neurokinin Receptor Antagonists API Price by Type (2021-2026) & (US$/Kg) Table 50. Global Neurokinin Receptor Antagonists API Price by Type (2027-2032) & (US$/Kg) Table 51. Global Neurokinin Receptor Antagonists API Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Neurokinin Receptor Antagonists API Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Neurokinin Receptor Antagonists API Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Neurokinin Receptor Antagonists API Revenue Market Share by Application (2021-2026) Table 55. Global Neurokinin Receptor Antagonists API Revenue Market Share by Application (2027-2032) Table 56. Global Neurokinin Receptor Antagonists API Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 57. Global Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 58. Global Neurokinin Receptor Antagonists API Sales by Application (2027-2032) & (Tons) Table 59. Global Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2026) Table 60. Global Neurokinin Receptor Antagonists API Sales Market Share by Application (2027-2032) Table 61. Global Neurokinin Receptor Antagonists API Price by Application (2021-2026) & (US$/Kg) Table 62. Global Neurokinin Receptor Antagonists API Price by Application (2027-2032) & (US$/Kg) Table 63. Zhejiang Tiantai Pharmaceutical Company Information Table 64. Zhejiang Tiantai Pharmaceutical Business Overview Table 65. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 67. Zhejiang Tiantai Pharmaceutical Recent Development Table 68. Humanwell Pharmaceutical Company Information Table 69. Humanwell Pharmaceutical Business Overview Table 70. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 72. Humanwell Pharmaceutical Recent Development Table 73. Viwit Company Information Table 74. Viwit Business Overview Table 75. Viwit Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Viwit Neurokinin Receptor Antagonists API Product Portfolio Table 77. Viwit Recent Development Table 78. Sichuan Qingmu Pharmaceutical Company Information Table 79. Sichuan Qingmu Pharmaceutical Business Overview Table 80. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 82. Sichuan Qingmu Pharmaceutical Recent Development Table 83. Kelun Pharmaceutical Company Information Table 84. Kelun Pharmaceutical Business Overview Table 85. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 87. Kelun Pharmaceutical Recent Development Table 88. Shandong New Time Pharmaceutical Company Information Table 89. Shandong New Time Pharmaceutical Business Overview Table 90. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 92. Shandong New Time Pharmaceutical Recent Development Table 93. Shandong Anxin Pharmaceutical Company Information Table 94. Shandong Anxin Pharmaceutical Business Overview Table 95. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 97. Shandong Anxin Pharmaceutical Recent Development Table 98. Qilu Pharmaceutical Company Information Table 99. Qilu Pharmaceutical Business Overview Table 100. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 102. Qilu Pharmaceutical Recent Development Table 103. Luoxin Pharmaceuticals Company Information Table 104. Luoxin Pharmaceuticals Business Overview Table 105. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolio Table 107. Luoxin Pharmaceuticals Recent Development Table 108. Lianyungang Runzhong Pharmaceutical Company Information Table 109. Lianyungang Runzhong Pharmaceutical Business Overview Table 110. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 112. Lianyungang Runzhong Pharmaceutical Recent Development Table 113. Wisdom Pharmaceutical Company Information Table 114. Wisdom Pharmaceutical Business Overview Table 115. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio Table 117. Wisdom Pharmaceutical Recent Development Table 118. Hansoh Pharma Company Information Table 119. Hansoh Pharma Business Overview Table 120. Hansoh Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 122. Hansoh Pharma Recent Development Table 123. United Pharma Company Information Table 124. United Pharma Business Overview Table 125. United Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. United Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 127. United Pharma Recent Development Table 128. Hangzhou Jiuyuan Gene Engineering Company Information Table 129. Hangzhou Jiuyuan Gene Engineering Business Overview Table 130. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 131. Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolio Table 132. Hangzhou Jiuyuan Gene Engineering Recent Development Table 133. Beijing Sjar Technology Development Company Information Table 134. Beijing Sjar Technology Development Business Overview Table 135. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 136. Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolio Table 137. Beijing Sjar Technology Development Recent Development Table 138. Zydus Animal Health And Investments Company Information Table 139. Zydus Animal Health And Investments Business Overview Table 140. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 141. Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolio Table 142. Zydus Animal Health And Investments Recent Development Table 143. Taizhou Crene Biotechnology Company Information Table 144. Taizhou Crene Biotechnology Business Overview Table 145. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 146. Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolio Table 147. Taizhou Crene Biotechnology Recent Development Table 148. Solara Active Pharma Sciences Company Information Table 149. Solara Active Pharma Sciences Business Overview Table 150. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 151. Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolio Table 152. Solara Active Pharma Sciences Recent Development Table 153. Procos Company Information Table 154. Procos Business Overview Table 155. Procos Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 156. Procos Neurokinin Receptor Antagonists API Product Portfolio Table 157. Procos Recent Development Table 158. Piramal Pharma Company Information Table 159. Piramal Pharma Business Overview Table 160. Piramal Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 161. Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 162. Piramal Pharma Recent Development Table 163. Optimus Pharma Company Information Table 164. Optimus Pharma Business Overview Table 165. Optimus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 166. Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 167. Optimus Pharma Recent Development Table 168. Murli Krishna Pharma Company Information Table 169. Murli Krishna Pharma Business Overview Table 170. Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 171. Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 172. Murli Krishna Pharma Recent Development Table 173. MSN Laboratories Company Information Table 174. MSN Laboratories Business Overview Table 175. MSN Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 176. MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolio Table 177. MSN Laboratories Recent Development Table 178. Jubilant Pharmova Company Information Table 179. Jubilant Pharmova Business Overview Table 180. Jubilant Pharmova Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 181. Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolio Table 182. Jubilant Pharmova Recent Development Table 183. Helsinn Advanced Synthesis Company Information Table 184. Helsinn Advanced Synthesis Business Overview Table 185. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 186. Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolio Table 187. Helsinn Advanced Synthesis Recent Development Table 188. Glenmark Life Sciences Company Information Table 189. Glenmark Life Sciences Business Overview Table 190. Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 191. Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolio Table 192. Glenmark Life Sciences Recent Development Table 193. Dr. Reddy's Laboratories Company Information Table 194. Dr. Reddy's Laboratories Business Overview Table 195. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 196. Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolio Table 197. Dr. Reddy's Laboratories Recent Development Table 198. Clearsynth Labs Company Information Table 199. Clearsynth Labs Business Overview Table 200. Clearsynth Labs Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 201. Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolio Table 202. Clearsynth Labs Recent Development Table 203. Camus Pharma Company Information Table 204. Camus Pharma Business Overview Table 205. Camus Pharma Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 206. Camus Pharma Neurokinin Receptor Antagonists API Product Portfolio Table 207. Camus Pharma Recent Development Table 208. Andenex Company Information Table 209. Andenex Business Overview Table 210. Andenex Neurokinin Receptor Antagonists API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 211. Andenex Neurokinin Receptor Antagonists API Product Portfolio Table 212. Andenex Recent Development Table 213. North America Neurokinin Receptor Antagonists API Revenue by Type (2021-2026) & (US$ Million) Table 214. North America Neurokinin Receptor Antagonists API Revenue by Type (2027-2032) & (US$ Million) Table 215. North America Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 216. North America Neurokinin Receptor Antagonists API Sales by Type (2027-2032) & (Tons) Table 217. North America Neurokinin Receptor Antagonists API Sales Price by Type (2021-2026) & (US$/Kg) Table 218. North America Neurokinin Receptor Antagonists API Sales Price by Type (2027-2032) & (US$/Kg) Table 219. North America Neurokinin Receptor Antagonists API Revenue by Application (2021-2026) & (US$ Million) Table 220. North America Neurokinin Receptor Antagonists API Revenue by Application (2027-2032) & (US$ Million) Table 221. North America Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 222. North America Neurokinin Receptor Antagonists API Sales by Application (2027-2032) & (Tons) Table 223. North America Neurokinin Receptor Antagonists API Sales Price by Application (2021-2026) & (US$/Kg) Table 224. North America Neurokinin Receptor Antagonists API Sales Price by Application (2027-2032) & (US$/Kg) Table 225. North America Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. North America Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. North America Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. North America Neurokinin Receptor Antagonists API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 229. North America Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 230. North America Neurokinin Receptor Antagonists API Sales by Country (2027-2032) & (Tons) Table 231. North America Neurokinin Receptor Antagonists API Sales Price by Country (2021-2026) & (US$/Kg) Table 232. North America Neurokinin Receptor Antagonists API Sales Price by Country (2027-2032) & (US$/Kg) Table 233. United States Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 234. Canada Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 235. Mexico Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 236. Europe Neurokinin Receptor Antagonists API Revenue by Type (2021-2026) & (US$ Million) Table 237. Europe Neurokinin Receptor Antagonists API Revenue by Type (2027-2032) & (US$ Million) Table 238. Europe Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 239. Europe Neurokinin Receptor Antagonists API Sales by Type (2027-2032) & (Tons) Table 240. Europe Neurokinin Receptor Antagonists API Sales Price by Type (2021-2026) & (US$/Kg) Table 241. Europe Neurokinin Receptor Antagonists API Sales Price by Type (2027-2032) & (US$/Kg) Table 242. Europe Neurokinin Receptor Antagonists API Revenue by Application (2021-2026) & (US$ Million) Table 243. Europe Neurokinin Receptor Antagonists API Revenue by Application (2027-2032) & (US$ Million) Table 244. Europe Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 245. Europe Neurokinin Receptor Antagonists API Sales by Application (2027-2032) & (Tons) Table 246. Europe Neurokinin Receptor Antagonists API Sales Price by Application (2021-2026) & (US$/Kg) Table 247. Europe Neurokinin Receptor Antagonists API Sales Price by Application (2027-2032) & (US$/Kg) Table 248. Europe Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. Europe Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 250. Europe Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 251. Europe Neurokinin Receptor Antagonists API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 252. Europe Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 253. Europe Neurokinin Receptor Antagonists API Sales by Country (2027-2032) & (Tons) Table 254. Europe Neurokinin Receptor Antagonists API Sales Price by Country (2021-2026) & (US$/Kg) Table 255. Europe Neurokinin Receptor Antagonists API Sales Price by Country (2027-2032) & (US$/Kg) Table 256. Germany Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 257. France Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 258. U.K. Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 259. Italy Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 260. Russia Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 261. Spain Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 262. Netherlands Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 263. Switzerland Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 264. Sweden Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 265. Poland Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 266. China Neurokinin Receptor Antagonists API Revenue by Type (2021-2026) & (US$ Million) Table 267. China Neurokinin Receptor Antagonists API Revenue by Type (2027-2032) & (US$ Million) Table 268. China Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 269. China Neurokinin Receptor Antagonists API Sales by Type (2027-2032) & (Tons) Table 270. China Neurokinin Receptor Antagonists API Sales Price by Type (2021-2026) & (US$/Kg) Table 271. China Neurokinin Receptor Antagonists API Sales Price by Type (2027-2032) & (US$/Kg) Table 272. China Neurokinin Receptor Antagonists API Revenue by Application (2021-2026) & (US$ Million) Table 273. China Neurokinin Receptor Antagonists API Revenue by Application (2027-2032) & (US$ Million) Table 274. China Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 275. China Neurokinin Receptor Antagonists API Sales by Application (2027-2032) & (Tons) Table 276. China Neurokinin Receptor Antagonists API Sales Price by Application (2021-2026) & (US$/Kg) Table 277. China Neurokinin Receptor Antagonists API Sales Price by Application (2027-2032) & (US$/Kg) Table 278. Asia Neurokinin Receptor Antagonists API Revenue by Type (2021-2026) & (US$ Million) Table 279. Asia Neurokinin Receptor Antagonists API Revenue by Type (2027-2032) & (US$ Million) Table 280. Asia Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 281. Asia Neurokinin Receptor Antagonists API Sales by Type (2027-2032) & (Tons) Table 282. Asia Neurokinin Receptor Antagonists API Sales Price by Type (2021-2026) & (US$/Kg) Table 283. Asia Neurokinin Receptor Antagonists API Sales Price by Type (2027-2032) & (US$/Kg) Table 284. Asia Neurokinin Receptor Antagonists API Revenue by Application (2021-2026) & (US$ Million) Table 285. Asia Neurokinin Receptor Antagonists API Revenue by Application (2027-2032) & (US$ Million) Table 286. Asia Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 287. Asia Neurokinin Receptor Antagonists API Sales by Application (2027-2032) & (Tons) Table 288. Asia Neurokinin Receptor Antagonists API Sales Price by Application (2021-2026) & (US$/Kg) Table 289. Asia Neurokinin Receptor Antagonists API Sales Price by Application (2027-2032) & (US$/Kg) Table 290. Asia Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 291. Asia Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 292. Asia Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 293. Asia Neurokinin Receptor Antagonists API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 294. Asia Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 295. Asia Neurokinin Receptor Antagonists API Sales by Country (2027-2032) & (Tons) Table 296. Asia Neurokinin Receptor Antagonists API Sales Price by Country (2021-2026) & (US$/Kg) Table 297. Asia Neurokinin Receptor Antagonists API Sales Price by Country (2027-2032) & (US$/Kg) Table 298. Japan Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 299. South Korea Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 300. India Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 301. Australia Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 302. Taiwan Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 303. Southeast Asia Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 304. SAMEA Neurokinin Receptor Antagonists API Revenue by Type (2021-2026) & (US$ Million) Table 305. SAMEA Neurokinin Receptor Antagonists API Revenue by Type (2027-2032) & (US$ Million) Table 306. SAMEA Neurokinin Receptor Antagonists API Sales by Type (2021-2026) & (Tons) Table 307. SAMEA Neurokinin Receptor Antagonists API Sales by Type (2027-2032) & (Tons) Table 308. SAMEA Neurokinin Receptor Antagonists API Sales Price by Type (2021-2026) & (US$/Kg) Table 309. SAMEA Neurokinin Receptor Antagonists API Sales Price by Type (2027-2032) & (US$/Kg) Table 310. SAMEA Neurokinin Receptor Antagonists API Revenue by Application (2021-2026) & (US$ Million) Table 311. SAMEA Neurokinin Receptor Antagonists API Revenue by Application (2027-2032) & (US$ Million) Table 312. SAMEA Neurokinin Receptor Antagonists API Sales by Application (2021-2026) & (Tons) Table 313. SAMEA Neurokinin Receptor Antagonists API Sales by Application (2027-2032) & (Tons) Table 314. SAMEA Neurokinin Receptor Antagonists API Sales Price by Application (2021-2026) & (US$/Kg) Table 315. SAMEA Neurokinin Receptor Antagonists API Sales Price by Application (2027-2032) & (US$/Kg) Table 316. SAMEA Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 317. SAMEA Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 318. SAMEA Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 319. SAMEA Neurokinin Receptor Antagonists API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 320. SAMEA Neurokinin Receptor Antagonists API Sales by Country (2021-2026) & (Tons) Table 321. SAMEA Neurokinin Receptor Antagonists API Sales by Country (2027-2032) & (Tons) Table 322. SAMEA Neurokinin Receptor Antagonists API Sales Price by Country (2021-2026) & (US$/Kg) Table 323. SAMEA Neurokinin Receptor Antagonists API Sales Price by Country (2027-2032) & (US$/Kg) Table 324. Brazil Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 325. Argentina Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 326. Chile Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 327. Colombia Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 328. Peru Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 329. Saudi Arabia Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 330. Israel Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 331. UAE Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 332. Turkey Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 333. Iran Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 334. Egypt Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Table 335. Key Raw Materials Table 336. Raw Materials Key Suppliers Table 337. Neurokinin Receptor Antagonists API Distributors List Table 338. Neurokinin Receptor Antagonists API Customers List Table 339. Research Programs/Design for This Report Table 340. Authors List of This Report Table 341. Secondary Sources Table 342. Primary Sources List of Figures Figure 1. Neurokinin Receptor Antagonists API Image Figure 2. Global Neurokinin Receptor Antagonists API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurokinin Receptor Antagonists API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Aprepitant Image Figure 5. Fezolinetant Image Figure 6. Fosaprepitant Image Figure 7. Rolapitant Image Figure 8. Maropitant Image Figure 9. Netupitant Image Figure 10. Global Neurokinin Receptor Antagonists API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Neurokinin Receptor Antagonists API Market Size Share 2021 VS 2025 VS 2032 Figure 12. Injections Image Figure 13. Tablets Image Figure 14. Oral Suspension Image Figure 15. Capsules Image Figure 16. Other Image Figure 17. Global Neurokinin Receptor Antagonists API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Neurokinin Receptor Antagonists API Revenue (2021-2032) & (US$ Million) Figure 19. Global Neurokinin Receptor Antagonists API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Neurokinin Receptor Antagonists API Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Neurokinin Receptor Antagonists API Revenue Market Share by Region (2021-2032) Figure 22. Global Neurokin

Scope & coverage.

Types
  • Aprepitant
  • Fezolinetant
  • Fosaprepitant
  • Rolapitant
  • Maropitant
  • Netupitant
Applications
  • Injections
  • Tablets
  • Oral Suspension
  • Capsules
  • Other
Companies covered
  • Zhejiang Tiantai Pharmaceutical
  • Humanwell Pharmaceutical
  • Viwit
  • Sichuan Qingmu Pharmaceutical
  • Kelun Pharmaceutical
  • Shandong New Time Pharmaceutical
  • Shandong Anxin Pharmaceutical
  • Qilu Pharmaceutical
  • Luoxin Pharmaceuticals
  • Lianyungang Runzhong Pharmaceutical
  • Wisdom Pharmaceutical
  • Hansoh Pharma
  • United Pharma
  • Hangzhou Jiuyuan Gene Engineering
  • Beijing Sjar Technology Development
  • Zydus Animal Health And Investments
  • Taizhou Crene Biotechnology
  • Solara Active Pharma Sciences
  • Procos
  • Piramal Pharma
  • Optimus Pharma
  • Murli Krishna Pharma
  • MSN Laboratories
  • Jubilant Pharmova
  • Helsinn Advanced Synthesis
  • Glenmark Life Sciences
  • Dr. Reddy's Laboratories
  • Clearsynth Labs
  • Camus Pharma
  • Andenex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neurokinin Receptor Antagonists API Market by Type
  3. 1.2.1 Global Neurokinin Receptor Antagonists API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Aprepitant
  5. 1.2.3 Fezolinetant
  6. 1.2.4 Fosaprepitant
  7. 1.2.5 Rolapitant
  8. 1.2.6 Maropitant
  9. 1.2.7 Netupitant
  10. 1.3 Neurokinin Receptor Antagonists API Market by Application
  11. 1.3.1 Global Neurokinin Receptor Antagonists API Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Injections
  13. 1.3.3 Tablets
  14. 1.3.4 Oral Suspension
  15. 1.3.5 Capsules
  16. 1.3.6 Other
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Neurokinin Receptor Antagonists API Market Dynamics
  1. 2.1 Neurokinin Receptor Antagonists API Industry Trends
  2. 2.2 Neurokinin Receptor Antagonists API Industry Drivers
  3. 2.3 Neurokinin Receptor Antagonists API Industry Opportunities and Challenges
  4. 2.4 Neurokinin Receptor Antagonists API Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neurokinin Receptor Antagonists API Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neurokinin Receptor Antagonists API Revenue by Region
  3. 3.2.1 Global Neurokinin Receptor Antagonists API Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neurokinin Receptor Antagonists API Revenue by Region (2021-2026)
  5. 3.2.3 Global Neurokinin Receptor Antagonists API Revenue by Region (2027-2032)
  6. 3.2.4 Global Neurokinin Receptor Antagonists API Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neurokinin Receptor Antagonists API Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neurokinin Receptor Antagonists API Sales by Region
  9. 3.4.1 Global Neurokinin Receptor Antagonists API Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neurokinin Receptor Antagonists API Sales by Region (2021-2026)
  11. 3.4.3 Global Neurokinin Receptor Antagonists API Sales by Region (2027-2032)
  12. 3.4.4 Global Neurokinin Receptor Antagonists API Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neurokinin Receptor Antagonists API Revenue by Manufacturers
  2. 4.1.1 Global Neurokinin Receptor Antagonists API Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neurokinin Receptor Antagonists API Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neurokinin Receptor Antagonists API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neurokinin Receptor Antagonists API Sales by Manufacturers
  6. 4.2.1 Global Neurokinin Receptor Antagonists API Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neurokinin Receptor Antagonists API Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neurokinin Receptor Antagonists API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neurokinin Receptor Antagonists API Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neurokinin Receptor Antagonists API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neurokinin Receptor Antagonists API Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neurokinin Receptor Antagonists API Manufacturers, Product Type & Application
  13. 4.7 Global Neurokinin Receptor Antagonists API Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neurokinin Receptor Antagonists API Market CR5 and HHI
  16. 4.8.2 2025 Neurokinin Receptor Antagonists API Tier 1, Tier 2, and Tier 3
5 Neurokinin Receptor Antagonists API Market by Type
  1. 5.1 Global Neurokinin Receptor Antagonists API Revenue by Type
  2. 5.1.1 Global Neurokinin Receptor Antagonists API Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neurokinin Receptor Antagonists API Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neurokinin Receptor Antagonists API Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neurokinin Receptor Antagonists API Sales by Type
  6. 5.2.1 Global Neurokinin Receptor Antagonists API Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurokinin Receptor Antagonists API Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Neurokinin Receptor Antagonists API Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neurokinin Receptor Antagonists API Price by Type
6 Neurokinin Receptor Antagonists API Market by Application
  1. 6.1 Global Neurokinin Receptor Antagonists API Revenue by Application
  2. 6.1.1 Global Neurokinin Receptor Antagonists API Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neurokinin Receptor Antagonists API Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neurokinin Receptor Antagonists API Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neurokinin Receptor Antagonists API Sales by Application
  6. 6.2.1 Global Neurokinin Receptor Antagonists API Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neurokinin Receptor Antagonists API Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Neurokinin Receptor Antagonists API Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neurokinin Receptor Antagonists API Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Tiantai Pharmaceutical
  2. 7.1.1 Zhejiang Tiantai Pharmaceutical Company Information
  3. 7.1.2 Zhejiang Tiantai Pharmaceutical Business Overview
  4. 7.1.3 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Tiantai Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  6. 7.1.5 Zhejiang Tiantai Pharmaceutical Recent Developments
  7. 7.2 Humanwell Pharmaceutical
  8. 7.2.1 Humanwell Pharmaceutical Company Information
  9. 7.2.2 Humanwell Pharmaceutical Business Overview
  10. 7.2.3 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Humanwell Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  12. 7.2.5 Humanwell Pharmaceutical Recent Developments
  13. 7.3 Viwit
  14. 7.3.1 Viwit Company Information
  15. 7.3.2 Viwit Business Overview
  16. 7.3.3 Viwit Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Viwit Neurokinin Receptor Antagonists API Product Portfolio
  18. 7.3.5 Viwit Recent Developments
  19. 7.4 Sichuan Qingmu Pharmaceutical
  20. 7.4.1 Sichuan Qingmu Pharmaceutical Company Information
  21. 7.4.2 Sichuan Qingmu Pharmaceutical Business Overview
  22. 7.4.3 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sichuan Qingmu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  24. 7.4.5 Sichuan Qingmu Pharmaceutical Recent Developments
  25. 7.5 Kelun Pharmaceutical
  26. 7.5.1 Kelun Pharmaceutical Company Information
  27. 7.5.2 Kelun Pharmaceutical Business Overview
  28. 7.5.3 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Kelun Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  30. 7.5.5 Kelun Pharmaceutical Recent Developments
  31. 7.6 Shandong New Time Pharmaceutical
  32. 7.6.1 Shandong New Time Pharmaceutical Company Information
  33. 7.6.2 Shandong New Time Pharmaceutical Business Overview
  34. 7.6.3 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shandong New Time Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  36. 7.6.5 Shandong New Time Pharmaceutical Recent Developments
  37. 7.7 Shandong Anxin Pharmaceutical
  38. 7.7.1 Shandong Anxin Pharmaceutical Company Information
  39. 7.7.2 Shandong Anxin Pharmaceutical Business Overview
  40. 7.7.3 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shandong Anxin Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  42. 7.7.5 Shandong Anxin Pharmaceutical Recent Developments
  43. 7.8 Qilu Pharmaceutical
  44. 7.8.1 Qilu Pharmaceutical Company Information
  45. 7.8.2 Qilu Pharmaceutical Business Overview
  46. 7.8.3 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Qilu Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  48. 7.8.5 Qilu Pharmaceutical Recent Developments
  49. 7.9 Luoxin Pharmaceuticals
  50. 7.9.1 Luoxin Pharmaceuticals Company Information
  51. 7.9.2 Luoxin Pharmaceuticals Business Overview
  52. 7.9.3 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Luoxin Pharmaceuticals Neurokinin Receptor Antagonists API Product Portfolio
  54. 7.9.5 Luoxin Pharmaceuticals Recent Developments
  55. 7.10 Lianyungang Runzhong Pharmaceutical
  56. 7.10.1 Lianyungang Runzhong Pharmaceutical Company Information
  57. 7.10.2 Lianyungang Runzhong Pharmaceutical Business Overview
  58. 7.10.3 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lianyungang Runzhong Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  60. 7.10.5 Lianyungang Runzhong Pharmaceutical Recent Developments
  61. 7.11 Wisdom Pharmaceutical
  62. 7.11.1 Wisdom Pharmaceutical Company Information
  63. 7.11.2 Wisdom Pharmaceutical Business Overview
  64. 7.11.3 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Wisdom Pharmaceutical Neurokinin Receptor Antagonists API Product Portfolio
  66. 7.11.5 Wisdom Pharmaceutical Recent Developments
  67. 7.12 Hansoh Pharma
  68. 7.12.1 Hansoh Pharma Company Information
  69. 7.12.2 Hansoh Pharma Business Overview
  70. 7.12.3 Hansoh Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hansoh Pharma Neurokinin Receptor Antagonists API Product Portfolio
  72. 7.12.5 Hansoh Pharma Recent Developments
  73. 7.13 United Pharma
  74. 7.13.1 United Pharma Company Information
  75. 7.13.2 United Pharma Business Overview
  76. 7.13.3 United Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 United Pharma Neurokinin Receptor Antagonists API Product Portfolio
  78. 7.13.5 United Pharma Recent Developments
  79. 7.14 Hangzhou Jiuyuan Gene Engineering
  80. 7.14.1 Hangzhou Jiuyuan Gene Engineering Company Information
  81. 7.14.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  82. 7.14.3 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hangzhou Jiuyuan Gene Engineering Neurokinin Receptor Antagonists API Product Portfolio
  84. 7.14.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  85. 7.15 Beijing Sjar Technology Development
  86. 7.15.1 Beijing Sjar Technology Development Company Information
  87. 7.15.2 Beijing Sjar Technology Development Business Overview
  88. 7.15.3 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Beijing Sjar Technology Development Neurokinin Receptor Antagonists API Product Portfolio
  90. 7.15.5 Beijing Sjar Technology Development Recent Developments
  91. 7.16 Zydus Animal Health And Investments
  92. 7.16.1 Zydus Animal Health And Investments Company Information
  93. 7.16.2 Zydus Animal Health And Investments Business Overview
  94. 7.16.3 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Zydus Animal Health And Investments Neurokinin Receptor Antagonists API Product Portfolio
  96. 7.16.5 Zydus Animal Health And Investments Recent Developments
  97. 7.17 Taizhou Crene Biotechnology
  98. 7.17.1 Taizhou Crene Biotechnology Company Information
  99. 7.17.2 Taizhou Crene Biotechnology Business Overview
  100. 7.17.3 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Taizhou Crene Biotechnology Neurokinin Receptor Antagonists API Product Portfolio
  102. 7.17.5 Taizhou Crene Biotechnology Recent Developments
  103. 7.18 Solara Active Pharma Sciences
  104. 7.18.1 Solara Active Pharma Sciences Company Information
  105. 7.18.2 Solara Active Pharma Sciences Business Overview
  106. 7.18.3 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Solara Active Pharma Sciences Neurokinin Receptor Antagonists API Product Portfolio
  108. 7.18.5 Solara Active Pharma Sciences Recent Developments
  109. 7.19 Procos
  110. 7.19.1 Procos Company Information
  111. 7.19.2 Procos Business Overview
  112. 7.19.3 Procos Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Procos Neurokinin Receptor Antagonists API Product Portfolio
  114. 7.19.5 Procos Recent Developments
  115. 7.20 Piramal Pharma
  116. 7.20.1 Piramal Pharma Company Information
  117. 7.20.2 Piramal Pharma Business Overview
  118. 7.20.3 Piramal Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Piramal Pharma Neurokinin Receptor Antagonists API Product Portfolio
  120. 7.20.5 Piramal Pharma Recent Developments
  121. 7.21 Optimus Pharma
  122. 7.21.1 Optimus Pharma Company Information
  123. 7.21.2 Optimus Pharma Business Overview
  124. 7.21.3 Optimus Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Optimus Pharma Neurokinin Receptor Antagonists API Product Portfolio
  126. 7.21.5 Optimus Pharma Recent Developments
  127. 7.22 Murli Krishna Pharma
  128. 7.22.1 Murli Krishna Pharma Company Information
  129. 7.22.2 Murli Krishna Pharma Business Overview
  130. 7.22.3 Murli Krishna Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Murli Krishna Pharma Neurokinin Receptor Antagonists API Product Portfolio
  132. 7.22.5 Murli Krishna Pharma Recent Developments
  133. 7.23 MSN Laboratories
  134. 7.23.1 MSN Laboratories Company Information
  135. 7.23.2 MSN Laboratories Business Overview
  136. 7.23.3 MSN Laboratories Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 MSN Laboratories Neurokinin Receptor Antagonists API Product Portfolio
  138. 7.23.5 MSN Laboratories Recent Developments
  139. 7.24 Jubilant Pharmova
  140. 7.24.1 Jubilant Pharmova Company Information
  141. 7.24.2 Jubilant Pharmova Business Overview
  142. 7.24.3 Jubilant Pharmova Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Jubilant Pharmova Neurokinin Receptor Antagonists API Product Portfolio
  144. 7.24.5 Jubilant Pharmova Recent Developments
  145. 7.25 Helsinn Advanced Synthesis
  146. 7.25.1 Helsinn Advanced Synthesis Company Information
  147. 7.25.2 Helsinn Advanced Synthesis Business Overview
  148. 7.25.3 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Helsinn Advanced Synthesis Neurokinin Receptor Antagonists API Product Portfolio
  150. 7.25.5 Helsinn Advanced Synthesis Recent Developments
  151. 7.26 Glenmark Life Sciences
  152. 7.26.1 Glenmark Life Sciences Company Information
  153. 7.26.2 Glenmark Life Sciences Business Overview
  154. 7.26.3 Glenmark Life Sciences Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Glenmark Life Sciences Neurokinin Receptor Antagonists API Product Portfolio
  156. 7.26.5 Glenmark Life Sciences Recent Developments
  157. 7.27 Dr. Reddy's Laboratories
  158. 7.27.1 Dr. Reddy's Laboratories Company Information
  159. 7.27.2 Dr. Reddy's Laboratories Business Overview
  160. 7.27.3 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 Dr. Reddy's Laboratories Neurokinin Receptor Antagonists API Product Portfolio
  162. 7.27.5 Dr. Reddy's Laboratories Recent Developments
  163. 7.28 Clearsynth Labs
  164. 7.28.1 Clearsynth Labs Company Information
  165. 7.28.2 Clearsynth Labs Business Overview
  166. 7.28.3 Clearsynth Labs Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  167. 7.28.4 Clearsynth Labs Neurokinin Receptor Antagonists API Product Portfolio
  168. 7.28.5 Clearsynth Labs Recent Developments
  169. 7.29 Camus Pharma
  170. 7.29.1 Camus Pharma Company Information
  171. 7.29.2 Camus Pharma Business Overview
  172. 7.29.3 Camus Pharma Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  173. 7.29.4 Camus Pharma Neurokinin Receptor Antagonists API Product Portfolio
  174. 7.29.5 Camus Pharma Recent Developments
  175. 7.30 Andenex
  176. 7.30.1 Andenex Company Information
  177. 7.30.2 Andenex Business Overview
  178. 7.30.3 Andenex Neurokinin Receptor Antagonists API Sales, Revenue, Price and Gross Margin (2021-2026)
  179. 7.30.4 Andenex Neurokinin Receptor Antagonists API Product Portfolio
  180. 7.30.5 Andenex Recent Developments
8 North America
  1. 8.1 North America Neurokinin Receptor Antagonists API Market Size by Type
  2. 8.1.1 North America Neurokinin Receptor Antagonists API Revenue by Type (2021-2032)
  3. 8.1.2 North America Neurokinin Receptor Antagonists API Sales by Type (2021-2032)
  4. 8.1.3 North America Neurokinin Receptor Antagonists API Price by Type (2021-2032)
  5. 8.2 North America Neurokinin Receptor Antagonists API Market Size by Application
  6. 8.2.1 North America Neurokinin Receptor Antagonists API Revenue by Application (2021-2032)
  7. 8.2.2 North America Neurokinin Receptor Antagonists API Sales by Application (2021-2032)
  8. 8.2.3 North America Neurokinin Receptor Antagonists API Price by Application (2021-2032)
  9. 8.3 North America Neurokinin Receptor Antagonists API Market Size by Country
  10. 8.3.1 North America Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neurokinin Receptor Antagonists API Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neurokinin Receptor Antagonists API Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Neurokinin Receptor Antagonists API Market Size by Type
  2. 9.1.1 Europe Neurokinin Receptor Antagonists API Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neurokinin Receptor Antagonists API Sales by Type (2021-2032)
  4. 9.1.3 Europe Neurokinin Receptor Antagonists API Price by Type (2021-2032)
  5. 9.2 Europe Neurokinin Receptor Antagonists API Market Size by Application
  6. 9.2.1 Europe Neurokinin Receptor Antagonists API Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neurokinin Receptor Antagonists API Sales by Application (2021-2032)
  8. 9.2.3 Europe Neurokinin Receptor Antagonists API Price by Application (2021-2032)
  9. 9.3 Europe Neurokinin Receptor Antagonists API Market Size by Country
  10. 9.3.1 Europe Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neurokinin Receptor Antagonists API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neurokinin Receptor Antagonists API Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Neurokinin Receptor Antagonists API Market Size by Type
  2. 10.1.1 China Neurokinin Receptor Antagonists API Revenue by Type (2021-2032)
  3. 10.1.2 China Neurokinin Receptor Antagonists API Sales by Type (2021-2032)
  4. 10.1.3 China Neurokinin Receptor Antagonists API Price by Type (2021-2032)
  5. 10.2 China Neurokinin Receptor Antagonists API Market Size by Application
  6. 10.2.1 China Neurokinin Receptor Antagonists API Revenue by Application (2021-2032)
  7. 10.2.2 China Neurokinin Receptor Antagonists API Sales by Application (2021-2032)
  8. 10.2.3 China Neurokinin Receptor Antagonists API Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neurokinin Receptor Antagonists API Market Size by Type
  2. 11.1.1 Asia Neurokinin Receptor Antagonists API Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neurokinin Receptor Antagonists API Sales by Type (2021-2032)
  4. 11.1.3 Asia Neurokinin Receptor Antagonists API Price by Type (2021-2032)
  5. 11.2 Asia Neurokinin Receptor Antagonists API Market Size by Application
  6. 11.2.1 Asia Neurokinin Receptor Antagonists API Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neurokinin Receptor Antagonists API Sales by Application (2021-2032)
  8. 11.2.3 Asia Neurokinin Receptor Antagonists API Price by Application (2021-2032)
  9. 11.3 Asia Neurokinin Receptor Antagonists API Market Size by Country
  10. 11.3.1 Asia Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neurokinin Receptor Antagonists API Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neurokinin Receptor Antagonists API Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neurokinin Receptor Antagonists API Market Size by Type
  2. 12.1.1 SAMEA Neurokinin Receptor Antagonists API Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neurokinin Receptor Antagonists API Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neurokinin Receptor Antagonists API Price by Type (2021-2032)
  5. 12.2 SAMEA Neurokinin Receptor Antagonists API Market Size by Application
  6. 12.2.1 SAMEA Neurokinin Receptor Antagonists API Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neurokinin Receptor Antagonists API Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neurokinin Receptor Antagonists API Price by Application (2021-2032)
  9. 12.3 SAMEA Neurokinin Receptor Antagonists API Market Size by Country
  10. 12.3.1 SAMEA Neurokinin Receptor Antagonists API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neurokinin Receptor Antagonists API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neurokinin Receptor Antagonists API Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neurokinin Receptor Antagonists API Value Chain Analysis
  2. 13.1.1 Neurokinin Receptor Antagonists API Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neurokinin Receptor Antagonists API Production Mode & Process
  6. 13.2 Neurokinin Receptor Antagonists API Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neurokinin Receptor Antagonists API Distributors
  9. 13.2.3 Neurokinin Receptor Antagonists API Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst